Ricci, Caterina
 Distribuzione geografica
Continente #
EU - Europa 996
NA - Nord America 927
AS - Asia 697
SA - Sud America 134
AF - Africa 20
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.778
Nazione #
US - Stati Uniti d'America 908
SG - Singapore 335
IT - Italia 295
DE - Germania 227
CN - Cina 175
BR - Brasile 114
SE - Svezia 112
FR - Francia 71
PL - Polonia 58
GB - Regno Unito 51
IN - India 47
IE - Irlanda 34
UA - Ucraina 31
FI - Finlandia 30
VN - Vietnam 29
ID - Indonesia 28
RU - Federazione Russa 24
HK - Hong Kong 19
NL - Olanda 17
KR - Corea 13
BD - Bangladesh 12
AT - Austria 11
CA - Canada 11
AR - Argentina 10
BE - Belgio 10
ZA - Sudafrica 9
ES - Italia 6
IR - Iran 6
IQ - Iraq 5
MX - Messico 5
TR - Turchia 5
MA - Marocco 4
RO - Romania 4
VE - Venezuela 4
AU - Australia 3
CH - Svizzera 3
EC - Ecuador 3
IL - Israele 3
JP - Giappone 3
LT - Lituania 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AW - Aruba 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HU - Ungheria 2
JO - Giordania 2
OM - Oman 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BG - Bulgaria 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
NI - Nicaragua 1
PE - Perù 1
PT - Portogallo 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.778
Città #
Singapore 172
Ashburn 134
Chandler 131
Warsaw 55
Rome 50
New York 41
Beijing 36
Dublin 34
Hefei 29
Ann Arbor 28
Milan 28
Hyderabad 26
Jakarta 26
Jacksonville 25
Los Angeles 23
San Mateo 21
Fairfield 20
The Dalles 20
Munich 18
Houston 17
Helsinki 16
Marseille 16
Hong Kong 15
Wilmington 15
Frankfurt am Main 14
Moscow 14
Bremen 13
Nürnberg 13
Dearborn 12
Redwood City 12
Boston 11
Ho Chi Minh City 11
Düsseldorf 10
Nanjing 10
Pescara 10
Woodbridge 10
Brussels 9
Buffalo 9
Cambridge 9
Chicago 9
Princeton 9
Seoul 9
Hanoi 8
Toronto 8
Washington 8
Dallas 7
Johannesburg 7
Kent 7
London 7
Santa Clara 7
Seattle 7
Amsterdam 6
Atlanta 6
Brooklyn 6
Chennai 6
Paris 6
São Paulo 6
Turku 6
Vienna 6
Boardman 5
Busto Arsizio 5
Cattolica 5
Council Bluffs 5
Phoenix 5
Portsmouth 5
Roubaix 5
Denver 4
Detroit 4
Lancaster 4
Manchester 4
Mcallen 4
New Haven 4
Nuremberg 4
Pisa 4
Ribeirão Preto 4
Stockholm 4
Allumiere 3
Asti 3
Baronissi 3
Changsha 3
Dhaka 3
Dong Ket 3
Giulianova 3
Izmir 3
Jeju City 3
Lauterbourg 3
Lawrence 3
Mexico City 3
Norwalk 3
Pavia 3
Poplar 3
Salt Lake City 3
San Diego 3
San Jose 3
Shanghai 3
Shenyang 3
Tokyo 3
Wroclaw 3
Abidjan 2
Addis Ababa 2
Totale 1.449
Nome #
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 291
NEOPLASIE DELLA VULVA E DELLA VAGINA 285
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 179
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 167
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 153
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 142
Chemotherapy resistance in epithelial ovarian cancer: Mechanisms and emerging treatments 131
Hpv and cytology testing in women undergoing 9-valent hpv opportunistic vaccination: A single-cohort follow up study 125
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 111
Real-world management of trabectedin/pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian cancer patients: A national survey 100
Locally Advanced Cervical Cancer in Pregnancy 99
Cancer and Mediterranean Diet: A Review 97
Recent progress in the use of pharmacotherapy for endometrial cancer 91
Health utilities lost and risk factors associated with HPV-induced diseases in men and women: The HPV Italian collaborative study group 85
Advanced and recurrent endometrial cancer: State of the art and future perspectives 84
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon? 83
PARP Inhibitors Resistance: Mechanisms and Perspectives 83
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 81
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 79
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 70
Colposcopy Accuracy and Diagnostic Performance: A Quality Control and Quality Assurance Survey in Italian Tertiary-Level Teaching and Academic Institutions—The Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV) 63
Are we facing a new colposcopic practice in the HPV vaccination era? Opportunities, challenges, and new perspectives 58
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 57
Long-term efficacy and safety of human papillomavirus vaccination 55
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors 48
Totale 2.817
Categoria #
all - tutte 12.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 5 16 2 17 12 51 15
2021/2022175 17 8 5 12 6 10 3 25 7 18 18 46
2022/2023449 48 56 22 64 21 63 23 30 62 17 30 13
2023/2024325 13 52 24 27 10 47 40 13 9 10 26 54
2024/2025605 24 6 61 22 47 24 35 21 65 105 118 77
2025/2026646 160 33 69 142 230 12 0 0 0 0 0 0
Totale 2.817